Trial Profile
Efficacy and Safety of Fexinidazole in Children at Least 6 Years Old and Weighing Over 20 kg With Human African Trypanosomiasis (HAT) Due to T.b. Gambiense: a Prospective, Multicentre, Open Study, plug-in to the Pivotal Study
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 25 Jun 2020
Price :
$35
*
At a glance
- Drugs Fexinidazole (Primary)
- Indications African trypanosomiasis
- Focus Therapeutic Use
- 23 Jun 2020 Status changed from active, no longer recruiting to completed.
- 22 Jan 2019 Pharmacokinetic-pharmacodynamic assessment of the hepatic and bone-marrow toxicities from six trials published in the Antimicrobial Agents and Chemotherapy
- 06 Oct 2016 Status changed from recruiting to active, no longer recruiting.